[
  {
    "ts": null,
    "headline": "Top Research Reports for Eli Lilly, American Express & Thermo Fisher",
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), American Express Company (AXP) and Thermo Fisher Scientific Inc. (TMO), as well as two micro-cap stocks, Steel Partners Holdings L.P. (SPLP) and Oil-Dri Corporation of America (ODC).",
    "url": "https://finnhub.io/api/news?id=121a4c8defe4a03d66ba020632abd090969c96635108f20a88d263a701052fee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744321380,
      "headline": "Top Research Reports for Eli Lilly, American Express & Thermo Fisher",
      "id": 133880596,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), American Express Company (AXP) and Thermo Fisher Scientific Inc. (TMO), as well as two micro-cap stocks, Steel Partners Holdings L.P. (SPLP) and Oil-Dri Corporation of America (ODC).",
      "url": "https://finnhub.io/api/news?id=121a4c8defe4a03d66ba020632abd090969c96635108f20a88d263a701052fee"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly and : 2025 Estimated Acquired IPR&D And Development Milestone Charges",
    "summary": "Estimated First Quarter 2025 Acquired In-Process Research and Development Charges Eli Lilly and Company currently expects that its reported financial results calculated in...",
    "url": "https://finnhub.io/api/news?id=3c38ef3919ef7c287d4239c25eb6bb92446781c638be11010257ba083b1c858c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744305550,
      "headline": "Eli Lilly and : 2025 Estimated Acquired IPR&D And Development Milestone Charges",
      "id": 133873095,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Estimated First Quarter 2025 Acquired In-Process Research and Development Charges Eli Lilly and Company currently expects that its reported financial results calculated in...",
      "url": "https://finnhub.io/api/news?id=3c38ef3919ef7c287d4239c25eb6bb92446781c638be11010257ba083b1c858c"
    }
  },
  {
    "ts": null,
    "headline": "Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know",
    "summary": "A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%, while the baseline 10% tariffs remained in place for most countries. This reminded investors that the global trade environment remained volatile, limiting the potential for sustained market gains.",
    "url": "https://finnhub.io/api/news?id=14e2d92735678ed9f65cc919a36522904cc36e69b65166bec7810166ca787618",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744305064,
      "headline": "Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know",
      "id": 133873303,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%, while the baseline 10% tariffs remained in place for most countries. This reminded investors that the global trade environment remained volatile, limiting the potential for sustained market gains.",
      "url": "https://finnhub.io/api/news?id=14e2d92735678ed9f65cc919a36522904cc36e69b65166bec7810166ca787618"
    }
  },
  {
    "ts": null,
    "headline": "Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.",
    "summary": "Robert F. Kennedy Jr. is the new Health Secretary. From fluoride, vaccines and beef tallow, here's how he might \"go wild\" on biotech stocks.",
    "url": "https://finnhub.io/api/news?id=ebe2fe3863e452ce1f401d2c50f1387550a453d0542dbec5a3f279f530e924c4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744300912,
      "headline": "Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.",
      "id": 133853253,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Robert F. Kennedy Jr. is the new Health Secretary. From fluoride, vaccines and beef tallow, here's how he might \"go wild\" on biotech stocks.",
      "url": "https://finnhub.io/api/news?id=ebe2fe3863e452ce1f401d2c50f1387550a453d0542dbec5a3f279f530e924c4"
    }
  },
  {
    "ts": null,
    "headline": "Pharma Stocks Rebound as Trump Announces a 90-Day Pause on Tariffs",
    "summary": "The news of a likely import tariff hurt the share price of pharma giants like Novo Nordisk (NVO), Eli Lilly (LLY) and AstraZeneca (AZN), but Trump's announcement of a pause on reciprocal tariffs offsets the losses.",
    "url": "https://finnhub.io/api/news?id=0abac995f7bcaecd967ebef3e739ebd3bc8c6f5e14619ecfc51696a28469ee4a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744289640,
      "headline": "Pharma Stocks Rebound as Trump Announces a 90-Day Pause on Tariffs",
      "id": 133853255,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The news of a likely import tariff hurt the share price of pharma giants like Novo Nordisk (NVO), Eli Lilly (LLY) and AstraZeneca (AZN), but Trump's announcement of a pause on reciprocal tariffs offsets the losses.",
      "url": "https://finnhub.io/api/news?id=0abac995f7bcaecd967ebef3e739ebd3bc8c6f5e14619ecfc51696a28469ee4a"
    }
  },
  {
    "ts": null,
    "headline": "Harbor Capital Factor U.S. Large Cap ETF Q4 2024 Commentary",
    "summary": "During the fourth quarter, Harbor Human Capital Factor US Large Cap ETF returned 2.72%, (at NAV) slightly underperforming CIBC Human Capital Index, which returned 2.80%.",
    "url": "https://finnhub.io/api/news?id=d513c95f6496914a3dbc2eb9f9d0b1f3e3ebba81993138c72ceab7f04b45ca60",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744283580,
      "headline": "Harbor Capital Factor U.S. Large Cap ETF Q4 2024 Commentary",
      "id": 133847889,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2170834274/image_2170834274.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "During the fourth quarter, Harbor Human Capital Factor US Large Cap ETF returned 2.72%, (at NAV) slightly underperforming CIBC Human Capital Index, which returned 2.80%.",
      "url": "https://finnhub.io/api/news?id=d513c95f6496914a3dbc2eb9f9d0b1f3e3ebba81993138c72ceab7f04b45ca60"
    }
  },
  {
    "ts": null,
    "headline": "Harbor Dividend Growth Leaders ETF Q4 2024 Commentary",
    "summary": "Harbor Dividend Growth Leaders ETF Q4 2024 Commentary",
    "url": "https://finnhub.io/api/news?id=4e4e7ace0952f54374a9a311db1fd617812c541c75ac31706ebafdbff6f351a3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744281540,
      "headline": "Harbor Dividend Growth Leaders ETF Q4 2024 Commentary",
      "id": 133845401,
      "image": "",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=4e4e7ace0952f54374a9a311db1fd617812c541c75ac31706ebafdbff6f351a3"
    }
  },
  {
    "ts": null,
    "headline": "Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks",
    "summary": "Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Eli Lilly (NYSE:LLY) and its peers.",
    "url": "https://finnhub.io/api/news?id=979e0ab6afdbb892dca536892cee29b0c83e9b4bc689b47a0fd9c614224d3d4d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744276506,
      "headline": "Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks",
      "id": 133844011,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Eli Lilly (NYSE:LLY) and its peers.",
      "url": "https://finnhub.io/api/news?id=979e0ab6afdbb892dca536892cee29b0c83e9b4bc689b47a0fd9c614224d3d4d"
    }
  },
  {
    "ts": null,
    "headline": "Trump’s tariff tirade and sudden calm keep Big Pharma on its toes",
    "summary": "A wild ride in an escalating trade war has torn at Big Pharma’s shares while global markets flag in the back-and-forth winds.",
    "url": "https://finnhub.io/api/news?id=036831929b30a0aadfa443efbb3aaa31b81d3b13a16d5ad9745f9400f1773e6b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744274896,
      "headline": "Trump’s tariff tirade and sudden calm keep Big Pharma on its toes",
      "id": 133844013,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "A wild ride in an escalating trade war has torn at Big Pharma’s shares while global markets flag in the back-and-forth winds.",
      "url": "https://finnhub.io/api/news?id=036831929b30a0aadfa443efbb3aaa31b81d3b13a16d5ad9745f9400f1773e6b"
    }
  },
  {
    "ts": null,
    "headline": "Harbor Long-Term Growers ETF Q4 2024 Commentary",
    "summary": "Harbor Long-Term Growers ETF Q4 2024 Commentary",
    "url": "https://finnhub.io/api/news?id=173fbd7b23fced2ec3e98b940b9ea88a5d7b0263c2a1d891a5af41eb92fdfb67",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744272600,
      "headline": "Harbor Long-Term Growers ETF Q4 2024 Commentary",
      "id": 133843133,
      "image": "",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=173fbd7b23fced2ec3e98b940b9ea88a5d7b0263c2a1d891a5af41eb92fdfb67"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Is Getting Into the Obesity Drug Business. The Stock Could Become the  Next Winner.",
    "summary": "Amgen Is Getting Into the Obesity Drug Business. The Stock Could Become the  Next Winner.",
    "url": "https://finnhub.io/api/news?id=503923e9b1ba50ec886b3df8a9c9e0f0e6ff8e7cac0d927e16c3dc62a15a64d7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744246800,
      "headline": "Amgen Is Getting Into the Obesity Drug Business. The Stock Could Become the  Next Winner.",
      "id": 133844744,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Amgen Is Getting Into the Obesity Drug Business. The Stock Could Become the  Next Winner.",
      "url": "https://finnhub.io/api/news?id=503923e9b1ba50ec886b3df8a9c9e0f0e6ff8e7cac0d927e16c3dc62a15a64d7"
    }
  }
]